STALLINGS ROBERT W

Director Robert W. Stallings bought 25,500 shares at blended avg $22.71 for $579,200.00 at TCBI.

Robert W. Stallings, a Director at Texas Capital Bancshares, executed 2 separate purchases totaling 25,500 shares for $579,200.00 (blended average $22.71) on March 5–6, 2026, increasing his stake by 17.0% to 175,087 shares post-transaction. The current market price of $92.19 is 13.0% below the 52-week high of $105.98, and the stock has declined 11.8% over the prior 30 days. Notably, Stallings has executed 5 consecutive purchases at TCBI within the prior 4 trading days (February 27 through March 5), suggesting sustained accumulation at a time when the stock is down from its recent peak. His cross-ticker track record shows 20 prior buys with a 100% 90-day win rate and average 90-day returns of +365.2%, though outcomes on the identical-ticker prior buys remain immeasurable as of this filing. The company faces material headwinds: annual revenue declined 37.4% year-over-year, though the P/E of 7.36 and net income of $105,210,000.00 indicate the business retains underlying profitability.

Director Robert W. Stallings purchases 45,000 shares of TCBI for $1.0M at blended avg $22.24; holdings rise to 149.6K shares.

Robert W. Stallings, Director, completed 2 separate purchases totaling 45,000 shares for $1,000,950.00 on 2026-03-03 and 2026-03-04 at a blended average price of $22.24. His post-transaction holdings increased to 149,587 shares, a 43.0% increase from prior holdings. The current stock price of $95.18 sits -10.2% from its 52-week high, placing the purchase prices substantially below recent highs. However, the broader context reveals material headwinds: annual revenue growth contracted -37.4% year-over-year, and P/E of 7.60 alongside positive net income of $105,210,000.00 reflects a compressed valuation backdrop. His cross-ticker track record shows an exceptional 100.00% 90-day win rate across 20 prior buys with average 90-day return of +359.7%, yet at TCBI specifically, 5 prior trades remain too recent to measure outcomes, and no same-ticker trade has yet demonstrated well-timed execution at the 90-day mark.

Director Stallings purchases 28,330 shares across 3 transactions (blended avg $30.77) totaling $871,733.80

Director Robert W Stallings acquired 28,330 shares through 3 separate open-market purchases on 2026-02-27 and 2026-03-02 at prices ranging from $22.22 to $94.86, expanding his holdings by +37.2% from 76,257 to 104,587 shares. The mixed price points—particularly the large 20,000-share block at $22.22 on 2026-03-02, well below the higher-priced earlier transactions—suggest opportunistic accumulation across a price range rather than a single conviction-timed entry. His cross-ticker track record shows 20 prior buys with 100% 90-day win rate and +345.4% average 90-day return; however, his 5 prior TCBI trades all remain within measurement windows too recent (2026-02-17 through 2026-03-03) for 90-day outcomes to be available. The current stock price of $95.53 sits 9.9% below the 52-week high of $105.98 and has declined 5.6% over the prior 30 days, placing the purchases within a recent downturn.

Director Stallings purchases 40,000 shares across 2 transactions for $888,000 at $22.20 average, fifth buy in 21 days, stock up 10.2% in 90 days.

Robert W. Stallings, a director at Texas Capital Bancshares, executed two separate purchases totaling 40,000 shares for $888,000.00 over consecutive trading days (February 23-24), with a blended average price of $22.20. This transaction follows four prior buys at TCBI within the preceding three weeks, establishing a pattern of accumulated purchases. The current stock price of $99.47 sits 6.1% below its 52-week high of $105.98, while the 90-day price change shows +10.2% and the 30-day change shows +1.9%. Notably, the five most recent TCBI transactions by this insider have not yet reached measurable outcomes at the 30- or 90-day mark, so the timing quality of this activity cannot yet be assessed against historical precedent.

Director Robert W. Stallings bought 10,000 shares of TCBI at blended average $22.13 in two transactions, adding 3.3% to holdings.

Director Stallings executed 2 purchases totaling 10,000 shares for $221,280.00 on consecutive days (2026-02-17 and 2026-02-18), at prices well below the current price of $104.64. His post-transaction holdings stand at 315,913 shares, up 3.3% from prior holdings. This represents the fourth buy in a 5-transaction sequence at TCBI over 15 days (2026-01-30 through 2026-02-17), indicating sustained accumulation. However, his prior 5 trades at TCBI remain unmeasurable at both 30-day and 90-day horizons, preventing evaluation of whether his recent TCBI buying pattern has historically predicted positive stock performance. The company's annual revenue declined 37.4% year-over-year, while the stock trades at a P/E of 8.35 and sits at -1.3% from its 52-week high.

Director Stallings buys 16,885 shares at $21.35 avg, expanding stake by 5.8% in two transactions Feb 4–5.

Robert W. Stallings, a director of Texas Capital Bancshares, executed two separate purchases totaling 16,885 shares (16.9K shares) for $360,578.60 ($360.6K) at a blended average price of $21.35 on February 4–5, 2026. This acquisition increased his holdings from 289,028 shares to 305,913 shares—a 5.8% increase in his stake. The transaction comes amid favorable near-term momentum: TCBI's stock is up 9.5% over the last 30 days and 20.4% over 90 days, trading at $104.47 versus a 52-week high of $105.98 (−1.4%). However, Stallings' own same-ticker history shows five prior buys at TCBI within recent days (January 23–February 3), all with outcome periods still unmeasurable, and his cross-ticker track record shows 0 of 0 prior buys were well-timed at the 90-day mark. Fundamental context presents mixed signals: net income stands at $105.2M and P/E is 15.85, but annual revenue contracted 37.4% year-over-year, signaling operational headwinds beneath the recent price appreciation.

Director Stallings buys 4,115 shares at $21.08 avg in 2 Feb-2026 transactions, reaching 289.0K holdings (+1.4%)

Director Robert W. Stallings purchased 4,115 shares in 2 separate transactions on 2026-02-02 and 2026-02-03 at a blended average price of $21.08, boosting his post-transaction holdings to 289.0K shares. The current price of $105.03 reflects substantial appreciation since the purchase dates and positive recent momentum (+11.3% over 30 days, +24.1% over 90 days). Across Stallings' cross-ticker track record, 20 prior open-market purchases have delivered an average 90-day return of +298.2% with a 100% win rate, though at TCBI specifically the measurable outcome from his most recent prior purchase (2025-10-28) showed a 90-day return of +368.7%. This filing adds to a pattern of consecutive purchases at TCBI across late January and early February 2026, with outcomes for the 2026-01-23, 2026-01-29, and 2026-01-30 purchases not yet measurable. The stock's strong 30-day and 90-day gains combined with the director's extended buying activity and outsized historical returns warrant attention to both the transaction timing and any catalysts driving the recent price recovery.

Director Robert W. Stallings bought 7,000 shares of TCBI at $20.92 avg; stock now $102.48, up 11.8% in 30d.

Robert W. Stallings, a director of Texas Capital Bancshares, executed 2 separate purchases totaling 7,000 (7.0K shares) for $146,445.00 ($146.4K) on 2026-01-29 and 2026-01-30 at a blended average price of $20.92, increasing his holdings from 277,913 to 284,913 shares (+2.5% vs pre-transaction holdings). The stock is currently trading at $102.48—a dramatic 389% premium to his transaction price—and has returned +11.8% over the prior 30 days and +22.4% over the prior 90 days. His prior trades at this same ticker show a strong pattern: 3 of 3 measurable prior buys (October 2025) posted 90-day returns of +326.7%, +333.2%, and +336.3%, demonstrating a 90-day win rate of 100% at TCBI. However, the current stock price of $102.48 is at the exact 52-week high, while underlying fundamentals show annual revenue contraction of -37.4% despite posted net income of $105.2M and a moderate P/E of 15.55. The combination of historically favorable entry timing at this ticker, strong recent price momentum, and contra-indicator of deteriorating revenue growth warrants close monitoring of fundamental developments.

Director Stallings bought 2,000 TCBI shares at $20.91; extends 5-trade pattern with 100% 90-day win rate at this ticker

Director Robert W. Stallings purchased 2,000 shares of Texas Capital Bancshares at $20.91 on 2026-01-23, bringing his post-transaction holdings to 277,913 shares (+0.7% vs pre-transaction). This buy is the sixth open-market purchase Stallings has made in TCBI stock; his prior 5 trades at this ticker from June through October 2025 all achieved 90-day positive returns ranging from +326.7% to +396.1%. Across all tickers in Stallings's insider transaction history, he has 20 prior open-market buys with an average 90-day return of +287.3% and a 100.00% win rate. His transaction occurred at $20.91 against a current price of $97.63 (52-week range $61.24–$102.28), and the stock is currently +4.1% over the trailing 30 days and +17.2% over the trailing 90 days. The company reports $105,210,000.00 in net income and a P/E of 14.81; however, annual revenue has declined 37.4% year-over-year. The persistent pattern of well-timed purchases at this specific ticker merits investor scrutiny alongside the company's near-term revenue headwinds.

Director Robert W. Stallings buys 5,000 TCBI shares at $20.83; prior TCBI purchases on 2025-10-27 and 2025-10-24 show recent accumulation pattern.

Robert W. Stallings, a director, executed a purchase of 5,000 shares at $20.83 on 2025-10-28, building holdings to 275,913 shares. This transaction is part of an active accumulation phase: Stallings purchased shares on 2025-10-27 and 2025-10-24 as well, suggesting sustained insider interest at current price levels. His prior measurable TCBI trades at this ticker (buys on 2025-06-11, 2025-06-02, and 2025-05-22) posted 90-day returns of +326.7%, +337.7%, and +321.9% respectively, establishing a pattern of well-timed entries at TCBI. The stock now trades at $82.14, down 8.5% from the 52-week high of $89.73, while the company reports net income of $105,210,000.00 and a P/E of 12.46, though annual revenue is down 37.4% year-over-year. The convergence of recent accumulation, historical execution success at this ticker, and current valuation warrant attention to Stallings' ongoing positioning.